An Open Label, Single Dose, Dose Rising, Multi-Centre Study to Assess the Tolerability and Pharmacokinetics of Ropinirole Immediate Release in Adolescent Patients With RLS
Phase of Trial: Phase I
Latest Information Update: 30 Sep 2015
At a glance
- Drugs Ropinirole (Primary)
- Indications Restless legs syndrome
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 07 Nov 2008 Status changed from recruiting to completed.
- 15 Oct 2008 Actual start date changed from Nov 2004 to Jun 2005 as reported by Clinicaltrials.gov
- 26 Nov 2007 Added trial centre.